跳至主要内容
临床试验/IRCT20181208041882N10
IRCT20181208041882N10已完成3 期

Evaluation of Amantadine efficacy compared to placebo in the treatment of cancer-related fatigue: a randomized, double-blind clinical trial.

Yazd University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Cancer patients who complain of fatigue as a side effect of treatment
  • Patients currently on a chemotherapy regimen are at risk for fatigue

排除标准

  • Patients with a hemoglobin level of less than 10 g / dl
  • Patients with a white blood cell count of less than 3,000 cells / mcl
  • Patients with a platelet count less than 10,000 cells / mcl
  • Patients with a serum creatinine greater than 2 mg / dl
  • Patients whose bilirubin level is 1.5 times normal and their alkaline phosphatase and SGOT levels are more than 3 times normal
  • Patients with melanoma

研究者

发起方
Yazd University of Medical Sciences

相似试验